[1]
|
Baidoun, F., Elshiwy, K., Elkeraie, Y., et al. (2021) Colorectal Cancer Epidemiology: Recent Trends and Impact on Out-comes. Current Drug Targets, 22, 998-1009. https://doi.org/10.2174/18735592MTEx9NTk2y
|
[2]
|
中国抗癌协会, 中国抗癌协会大肠癌专业委员会. 中国恶性肿瘤整合诊治指南-直肠癌部分[J]. 中华结直肠疾病电子杂志, 2022, 11(2): 89-103.
|
[3]
|
覃勇军. 结直肠癌的发病因素及高危人群的预防对策[J]. 吉林学, 2021, 42(6): 1350-1352.
|
[4]
|
Alice, E., Giancotti, F.G. and Rustgi, A.K. (2023) Metastatic Colorectal Cancer: Mechanisms and Emerging Therapeutics. Trends in Pharmacological Sciences, 44, 222-236. https://doi.org/10.1016/j.tips.2023.01.003
|
[5]
|
张宇, 王敏, 候艳华, 等. PD-L1基因多态性对接受卡培他滨辅助化疗结直肠癌患者的生存期影响[J]. 医学研究生学报, 2019, 32(4): 391-396.
|
[6]
|
Sakkas, H., Bozidis, P., Bozidis, P., et al. (2020) Nutritional Status and the Influence of the Vegan Diet on the Gut Microbiota and Human Health. Medicina, 56, Article 88. https://doi.org/10.3390/medicina56020088
|
[7]
|
Baek, S.J., Kim, S.H. and Lee, C.K. (2014) Relationship between the Severity of Diversion Colitis and the Compsition of Colonic Bacteria: A Prospec-tive Study. Gut and Liver, 8, 170-176. https://doi.org/10.5009/gnl.2014.8.2.170
|
[8]
|
梁淑文, 屈昌民, 王晓英, 等. 结肠癌患者肠道菌群变化的临床研究[J]. 中国微生态学杂志, 2017, 29(1): 62-65.
|
[9]
|
桂冠, 易健, 张善金, 等. 粪菌移植疗法治疗晚期结直肠癌FOLFIRI化疗方案相关难治性腹泻的效果观察[J]. 中国医学创新, 2021, 18(30): 10-14.
|
[10]
|
Ratajczak, W., Rył, A., Mizerski, A., et al. (2019) Immunomodulatory Potential of Gut Microbi-ome-Derived Short-Chain Fatty Acids (SCFAs). Acta Biochimica Polonica, 66, 1-12. https://doi.org/10.18388/abp.2018_2648
|
[11]
|
Morrison, D.J. and Preston, T. (2016) Formation of Short Chain Fatty Acids by the Gut Microbiota and Their Impact on Human Metabolism. Gut Microbes, 7, 189-200. https://doi.org/10.1080/19490976.2015.1134082
|
[12]
|
Chattopadhyay, I., Dhar, R., Pethusamy, K., et al. (2021) Exploring the Role of Gut Microbiome in Colon Cancer. Applied Biochemistry and Biotechnology, 193, 1780-1799. https://doi.org/10.1007/s12010-021-03498-9
|
[13]
|
Vinay, D.S., Ryan, E.P., Pawelec, G., et al. (2015) Immune Evasion in Cancer: Mechanistic Basis and Therapeutic Strategies. Seminars in Cancer Biology, 35, S185-S198. https://doi.org/10.1016/j.semcancer.2015.03.004
|
[14]
|
Xiao, Y. and Yu, D. (2021) Tumor Microenvironment as a Therapeutic Target in Cancer. Pharmacology & Therapeutics, 221, Article ID: 107753. https://doi.org/10.1016/j.pharmthera.2020.107753
|
[15]
|
杜娜雯, 白日兰, 崔久嵬. 肿瘤免疫逃逸机制及治疗策略[J]. 中国肿瘤生物治疗杂志, 2019, 26(4): 454-462.
|
[16]
|
He, Y.B., Huang, J.L., Li, Q.R., et al. (2022) Gut Micro-biota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy. Cancers, 14, Article 5317. https://doi.org/10.3390/cancers14215317
|
[17]
|
Chandel, D., Sharma, M., Chawla, V., Sachdeva, N. and Shukla, G. (2019) Isolation, Characterization and Identification of Antigenotoxic and Anticancerous Indigenous Probiotics and Their Prophylactic Potential in Experimental Colon Carcinogenesis. Scientific Reports, 9, Article No. 14769. https://doi.org/10.1038/s41598-019-51361-z
|
[18]
|
Shi, L., Sheng, J., Wang, M., et al. (2019) Combination Therapy of TGF-β Blockadeand Commensal-Derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression. Theranostics, 9, 4115-4129.
https://doi.org/10.7150/thno.35131
|
[19]
|
Yang, Z., Zhang, B., Li, D., et al. (2010) Mast Cells Mobilize Mye-loid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment via IL-17 Pathway in Murine Hepatocarci-noma Model. PLOS ONE, 5, e8922.
https://doi.org/10.1371/journal.pone.0008922
|
[20]
|
Jin, C., Lagoudas, G.K., Zhao, C., et al. (2019) Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell, 176, 998-1013. https://doi.org/10.1016/j.cell.2018.12.040
|
[21]
|
Yu, H., Li, X.X., Han, X., et al. (2023) Fecal Microbiota Transplantation Inhibits Colorectal Cancer Progression: Reversing Intestinal Microbial Dysbiosis to Enhance Anti-Cancer Immune Responses. Frontiers in Microbiology, 14, Article 1126808. https://doi.org/10.3389/fmicb.2023.1126808
|
[22]
|
Pishesha, N., Harmand, T.J. and Ploegh, H.L. (2022) A Guide to Antigen Processing and Presentation. Nature Reviews Immunology, 22, 751-764.
|
[23]
|
许承明. 肠道菌群对肿瘤免疫微环境中抗原提呈细胞功能的影响[D]: [博士学位论文]. 西安: 第四军医大学, 2017.
|
[24]
|
Yang, W.J., Yu, T.M., Huang, X.S, et al. (2020) Intestinal Microbiota-Derived Short-Chain Fatty Acids Regulation of Immune Cell IL-22 Pro-duction and Gut Immunity. Nature Communications, 11, Article No. 4457.
https://doi.org/10.1038/s41467-020-18262-6
|
[25]
|
Luu, M., Riester, Z., Baldrich, A., et al. (2021) Microbial Short-Chain Fatty Acids Modulate CD8+ T Cell Responses and Improve Adoptive Immunotherapy for Cancer. Nature Communications, 12, Article No. 4077.
https://doi.org/10.1038/s41467-021-24331-1
|
[26]
|
Russick, J., Joubert, P.E., Gillard-Bocquet, M., et al. (2020) Natural Killer Cells in the Human Lung Tumor Microenvironment Display Immune Inhibitory Functions. Journal for ImmunoTherapy of Cancer, 8, e001054.
https://doi.org/10.1136/jitc-2020-001054
|
[27]
|
Poggi, A., Benelli, R., Venè, R., et al. (2019) Human Gut-Associated Natural Killer Cells in Health and Disease. Frontiers in Immunology, 10, Article 441580. https://doi.org/10.3389/fimmu.2019.00961
|
[28]
|
Gaggero, S., Witt, K., Carlsten, M., et al. (2021) Cytokines Or-chestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy. Frontiers in Immunology, 11, Article 621225. https://doi.org/10.3389/fimmu.2020.621225
|
[29]
|
Yu, Q., Newsome, R.C., Beveridge, M., et al. (2022) Intestinal Microbiota Modulates Pancreatic Carcinogenesis through Intratumoral Natural Killer Cells. Gut Microbes, 14, Article ID: 2112881.
https://doi.org/10.1080/19490976.2022.2112881
|
[30]
|
Bakhtiyari, M., Liaghat, M., Aziziyan, F., et al. (2023) The Role of Bone Marrow Microenvironment (BMM) Cells in Acute Myeloid Leukemia (AML) Progression: Immune Checkpoints, Metabolic Checkpoints, and Signaling Pathways. Cell Communication and Signaling, 21, Article No. 252. https://doi.org/10.1186/s12964-023-01282-2
|
[31]
|
Dan, W.Y., Zhou, G.Z., Peng, L.H., et al. (2023) Update and Latest Advances in Mechanisms and Management of Colitis-Associated Colorectal Cancer. World Journal of Gastroin-testinal Oncology, 15, 1317-1331.
https://doi.org/10.4251/wjgo.v15.i8.1317
|
[32]
|
Yang, X.X., Guo, Y.X., Chen, C., et al. (2021) Interaction between Intestinal Microbiota and Tumour Immunity in the Tumour Microenvironment. Immunology, 164, 476-493. https://doi.org/10.1111/imm.13397
|
[33]
|
Cheng, M., Qian, L., Shen, G.D., et al. (2014) Microbiota Modulate Tu-moral Immune Surveillance in Lung Through a γδ T17 Immune Cell-Dependent Mechanism. Cancer Research, 74, 4030-4041.
https://doi.org/10.1158/0008-5472.CAN-13-2462
|
[34]
|
Moreno Ayala, M.A., Li, Z. and DuPage, M. (2019) Treg Programming and Therapeutic Reprogramming in Cancer. Immunology, 157, 198-209. https://doi.org/10.1111/imm.13058
|
[35]
|
Wang, Y.A., Li, X.L., Mo, Y.Z., et al. (2018) Effects of Tumor Metabolic Microenvironment on Regulatory T Cells. Molecular Cancer, 17, Article No. 168. https://doi.org/10.1186/s12943-018-0913-y
|
[36]
|
Noyes, D., Bag, A., Oseni, S., et al. (2022) Tumor-Associated Tregs Obstruct Antitumor Immunity by Promoting T Cell Dysfunction and Restricting Clonal Diversity in Tu-mor-Infiltrating CD8+ T Cells. Journal for ImmunoTherapy of Cancer, 10, e004605. https://doi.org/10.1136/jitc-2022-004605
|
[37]
|
张妍生, 王雅楠, 等. M1/M2型巨噬细胞在调控结直肠癌肿瘤微环境中的研究进展[J]. 现代医药卫生, 2022, 38(19): 3322-3325.
|
[38]
|
Boutilier, A.J. and Elsawa, S.F. (2021) Mac-rophage Polarization States in the Tumor Microenvironment. Molecular Sciences, 22, Article 6995. https://doi.org/10.3390/ijms22136995
|
[39]
|
Schulthess, J., Pandey, S., Capitani, M., et al. (2019) The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages. Immunity, 50, 432-445.E7. https://doi.org/10.1016/j.immuni.2018.12.018
|
[40]
|
Sun, M., Wu, W., Chen, L., et al. (2018) Microbiota-Derived Short-Chain Fatty Acids Promote Th1 Cell IL-10 Production to Maintain Intestinal Homeostasis. Nature Communica-tions, 9, Article No. 3555.
https://doi.org/10.1038/s41467-018-05901-2
|
[41]
|
Wan, G., Xie, M., Yu, H. and Chen, H.Y. (2018) Intestinal Dysbacteriosis Activates Tumor-Associated Macrophages to Promote Epithelial-Mesenchymal Transition of Colorectal Cancer. Innate Immunity, 24, 480-489.
https://doi.org/10.1177/1753425918801496
|